Online citations, reference lists, and bibliographies.
← Back to Search

Controlled Delivery Of Brain Derived Neurotrophic Factor And Gold-Nanoparticles From Chitosan/TPP Nanoparticles For Tissue Engineering Applications

Reihaneh Seyedebrahimi, Shahnaz Razavi, J. Varshosaz
Published 2020 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract Brain derived neurotrophic factor (BDNF) is highly effective in the treatment of various diseases, and selected for growth factor delivery system. Also, gold-nanoparticles (AuNPs) plays the paramount role in diagnosis and treatment of diseases. The aim of this study is to encapsulate BDNF and AuNPs in chitosan nanoparticles and its effect on human adipose derived stem cells (h-ADSCs) proliferation was evaluated. The ratio of 1:3 chitosan/TPP was determined as the optimum ratio, BDNF or AuNPs were added to 0.1% chitosan solution for preparation of nanoparticles. The release rate of BDNF and AuNPs were assessed by Bradford test and inductive coupled plasma optical emission spectrometry technique, respectively. In this study, BDNF and AuNPs loading efficiency were 89.46 ± 2.77 (%) and 93.8 ± 2.12 (%), respectively. The kinetic release of BDNF is 83.28 ± 2.22 (%) and AuNPs release rate was 48.4 ± 0.108(%), during the 7 days. MTT findings demonstrated h-ADSCs viability in the presence encapsulated BDNF and AuNPs is significantly more than control group on 3 and 7 days ( p  < 0.05). These findings indicate the controlled release of encapsulated BDNF and AuNPs, and synergist effects of nanoparticles on h-ADSCs viability; it suggests an efficient delivery of BDNF and AuNPs, for tissue engineering.
This paper references
10.1016/S0168-3659(01)00446-1
Effect of protein molecular weight on release from micron-sized PLGA microspheres.
M. Sandor (2001)
10.1007/S11814-010-0485-Z
Preparation of chitosan nanoparticles for encapsulation and release of protein
Somnuk Jarudilokkul (2011)
10.1023/B:PHAM.0000012145.49054.6c
Pharmaceutical Prospects for RNA Interference
R. Schiffelers (2004)
10.1016/j.omtm.2018.03.001
Seizure-Suppressant and Neuroprotective Effects of Encapsulated BDNF-Producing Cells in a Rat Model of Temporal Lobe Epilepsy
C. Falcicchia (2018)
10.1371/journal.pone.0058211
Gold- and Silver Nanoparticles Affect the Growth Characteristics of Human Embryonic Neural Precursor Cells
E. Söderstjerna (2013)
10.1016/S0378-5173(02)00381-2
Oral absorption of insulin encapsulated in artificial chyles of bile salts, palmitic acid and alpha-tocopherol dispersions.
M. S. Mesiha (2002)
10.1016/j.brainres.2004.02.083
Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice
M. Selley (2005)
10.1038/sj.clpt.6100400
Nanoparticles in Medicine: Therapeutic Applications and Developments
L. Zhang (2008)
10.1021/BM061140P
Physical, mechanical, and antibacterial properties of chitosan/PEO blend films.
S. Zivanovic (2007)
10.1038/s41398-017-0031-4
Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
C. Yang (2017)
10.1016/j.msec.2016.09.003
Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
S. Anandhakumar (2017)
10.3390/polym10010001
Silica Modified by Alcohol Polyoxyethylene Ether and Silane Coupling Agent Together to Achieve High Performance Rubber Composites Using the Latex Compounding Method
J. Zheng (2017)
10.1016/j.msec.2016.08.059
Laser fabrication of Ag-HA nanocomposites on Ti6Al4V implant for enhancing bioactivity and antibacterial capability.
Xiangmei Liu (2017)
動的銅表面上のステップバンチングによる異方性グラフェン成長 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター
Hayashi Kenjiro (2013)
10.1016/j.ijbiomac.2018.08.017
Zinc-chitosan nanoparticles induced apoptosis in human acute T-lymphocyte leukemia through activation of tumor necrosis factor receptor CD95 and apoptosis-related genes.
K. Saravanakumar (2018)
10.1038/nrd2591
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
10.1016/S0169-409X(01)00189-2
Topical formulations and wound healing applications of chitosan.
H. Ueno (2001)
10.1371/journal.pone.0194778
Long-term delivery of brain-derived neurotrophic factor (BDNF) from nanoporous silica nanoparticles improves the survival of spiral ganglion neurons in vitro
Nadeschda Schmidt (2018)
10.1016/j.yjmcc.2017.07.007
BDNF - A key player in cardiovascular system.
E. Pius-Sadowska (2017)
10.1016/j.scitotenv.2016.04.062
Multidrug resistance phenotypes are widespread over different bacterial taxonomic groups thriving in surface water.
Carlos Narciso-da-Rocha (2016)
10.2217/nnm-2016-0040
Nanomaterial-modulated autophagy: underlying mechanisms and functional consequences.
Wei Zheng (2016)
10.1007/s40089-017-0224-0
Electrosprayed chitosan nanoparticles: facile and efficient approach for bacterial transformation
Morteza Abyadeh (2017)
10.1007/s13346-012-0064-4
Drug release from nanomedicines: selection of appropriate encapsulation and release methodology
S. J. Wallace (2012)
10.1016/J.BIOENG.2006.05.026
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis.
D. Emerich (2006)
10.1371/journal.pone.0064037
Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease
C. Giampà (2013)
10.1016/j.micpath.2016.09.010
Chitosan coated Ag/ZnO nanocomposite and their antibiofilm, antifungal and cytotoxic effects on murine macrophages.
Rajagopalan Thaya (2016)
10.1242/jcs.135384
Embryonic stem cells stably expressing BDNF–GFP exhibit a BDNF-release-dependent enhancement of neuronal differentiation
J. Leschik (2013)
10.1161/ATVBAHA.112.248930
Brain-Derived Neurotrophic Factor Protects Against Cardiac Dysfunction After Myocardial Infarction via a Central Nervous System–Mediated Pathway
S. Okada (2012)
10.1080/10717544.2016.1199609
Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury
I. Khalin (2016)
10.1007/s10571-012-9895-2
Effect of Leukemia Inhibitory Factor on the Myelinogenic Ability of Schwann-Like Cells Induced from Human Adipose-Derived Stem Cells
S. Razavi (2012)
10.1016/j.neuroscience.2017.04.047
Human neural stem/progenitor cells derived from the olfactory epithelium express the TrkB receptor and migrate in response to BDNF
L. Ortíz-López (2017)
10.1038/nrd3366
Potential therapeutic uses of BDNF in neurological and psychiatric disorders
A. Nagahara (2011)
10.1016/J.LIMNO.2016.06.003
Fish predation on sympatric and allopatric prey—A case study of Ponto-Caspian gobies, European bullhead and amphipods
Dagmara Blonska (2016)
10.1021/ja2084338
Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake.
Carl D. Walkey (2012)
10.1146/annurev-chembioeng-073009-100847
Polymers for drug delivery systems.
William B. Liechty (2010)
10.3390/md14050090
Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation
Liliana Aranha Caetano (2016)
10.1016/j.biomaterials.2015.04.047
In vivo studies of silk based gold nano-composite conduits for functional peripheral nerve regeneration.
S. Das (2015)
10.4103/2277-9175.151570
Neurotrophic factors and their effects in the treatment of multiple sclerosis
S. Razavi (2015)
10.1002/jnr.23132
Pain‐ameliorating effects of minocycline: An emerging treatment modality
S. Kapoor (2013)
10.3390/md14010005
New Drugs from Marine Organisms in Alzheimer’s Disease
P. Russo (2015)
10.1073/pnas.1422282112
How many scientific papers are not original?
Michael Lesk (2014)
10.2174/157341308783591861
Magnetic Nanoparticles for Cancer Therapy
G. F. Goya (2008)
10.1016/j.brainres.2005.01.007
Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects
B. A. Hoshaw (2005)
10.1016/S0168-3659(99)00133-9
Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance.
K. Kataoka (2000)
10.1590/S1678-91992012000100001
Hepatitis C therapy: now more than a coin toss to achieve the cure
Barbosa An (2012)
10.1016/j.ijbiomac.2018.07.132
Production and characterization of hydrophilic and hydrophobic sunflower protein isolate nanofibers by electrospinning method.
Elaheh Shanesazzadeh (2018)
10.3390/ijms19030754
Gold Nanoparticle-Induced Cell Death and Potential Applications in Nanomedicine
Hainan Sun (2018)
10.1016/j.ijpharm.2013.07.034
Chitosan nanoparticles: preparation, size evolution and stability.
A. Rampino (2013)
10.3109/21691401.2014.898647
Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis
A. Urbanska (2016)
10.1016/j.micpath.2017.06.016
The inhibitory impacts of Lactobacillus rhamnosus GG-derived extracellular vesicles on the growth of hepatic cancer cells.
E. Behzadi (2017)
10.1242/jcs.120907
Mechanisms that link the oncogenic epithelial–mesenchymal transition to suppression of anoikis
S. Frisch (2013)
10.1016/J.LIMNO.2016.09.007
Protective effects of chitosan against the hazardous effects of zinc oxide nanoparticle in freshwater crustaceans Ceriodaphnia cornuta and Moina micrura
S. Vijayakumar (2016)
10.1083/jcb.201502100
BDNF modulates heart contraction force and long-term homeostasis through truncated TrkB.T1 receptor activation
G. Fulgenzi (2015)
10.1016/j.ijpharm.2013.08.003
Yield strength of microcrystalline cellulose: experimental evidence by dielectric spectroscopy.
Kailas S. Khomane (2013)
10.1007/s10856-017-6008-2
Preparation of NGF encapsulated chitosan nanoparticles and its evaluation on neuronal differentiation potentiality of canine mesenchymal stem cells
B. Mili (2017)
10.1016/j.biomaterials.2015.02.118
Food-associated stimuli enhance barrier properties of gastrointestinal mucus.
H. Yildiz (2015)
10.1208/pt070250
Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note
D. Bhumkar (2008)
10.1016/j.jfda.2014.10.008
Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review.
M. A. Elgadir (2015)
10.1007/s00726-005-0289-3
Strategies to improve plasma half life time of peptide and protein drugs
M. Werle (2005)
10.1016/j.tibtech.2008.04.005
Multifunctional nanoparticles--properties and prospects for their use in human medicine.
Nuria Sanvicens (2008)
10.1016/j.expneurol.2012.09.011
Exogenous BDNF enhances the integration of chronically injured axons that regenerate through a peripheral nerve grafted into a chondroitinase-treated spinal cord injury site
Veronica J Tom (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar